RNTX Insider Trading Activity and SEC Form 4 Filings
RNTX insider trading summary
Over the past 12 months, insiders at Rein Therapeutics, Inc. (RNTX) reported 10 open-market purchases worth $713K by 7 insiders and no sales on SEC Form 4. Net insider buying was $713K.
Latest RNTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 27, 2026 | Rickenbach Josef H Von | Insider | Buy | $5K (4,500 @ $1.07) |
| May 26, 2026 | Rickenbach Josef H Von | Insider | Buy | $24K (23,190 @ $1.06) |
| May 22, 2026 | Rickenbach Josef H Von | Insider | Buy | $17K (15,950 @ $1.05) |
| May 21, 2026 | Rickenbach Josef H Von | Insider | Buy | $4K (3,420 @ $1.04) |
| Apr 30, 2026 | James Brian Windsor | See Remarks | Buy | $25K (25,000 @ $1.00) |
| Nov 14, 2025 | Voss Capital, LP | 10% Owner | Buy | $128K (104,183 @ $1.22) |
| Nov 14, 2025 | Voss Value-Oriented Special Situations Fund, LP | 10% Owner | Buy | $128K (104,183 @ $1.22) |
| Nov 14, 2025 | Voss Value Master Fund, LP | 10% Owner | Buy | $128K (104,183 @ $1.22) |
| Nov 14, 2025 | Travis W. Cocke | 10% Owner | Buy | $128K (104,183 @ $1.22) |
| Nov 14, 2025 | Voss Advisors GP, LLC | 10% Owner | Buy | $128K (104,183 @ $1.22) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.